Storys zum Thema Forschung
-
Sprache:
Englisch
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
- Ein Dokumentmehr
Acousia Therapeutics to present its clinical Phase 2 PROHEAR study on hearing loss treatment candidate ACOU085 at upcoming conferences
Tübingen, Germany (ots) - Acousia Therapeutics GmbH, a Tübingen-based clinical stage biotech company focused on the enhancement and preservation of natural hearing, will be presenting the ACOU085 Phase 2 PROHEAR clinical study at the HansonWade 4th Inner Ear Disorders Therapeutics Summit in Boston (MA) from August ...
mehrESSL - European Severe Storms Laboratory
Europe needs Twisters campaign
Wiener Neustadt, Austria (ots) - Researchers from all over Europe are organising high-density measurements of severe storms, similar to the new film Twisters. Severe weather researchers from 14 European countries want to work together to get to the bottom of severe thunderstorms so that they can provide better warnings in future. To this aim, they are currently planning the largest European measurement campaign on severe thunderstorms to date. "We want to use the latest ...
mehrRenowned Public Health Expert Prof. Siegal Sadetzki Joins Briya
Tel Aviv, Israel (ots/PRNewswire) - Briya, a leading medical data retrieval network, proudly announces the appointment of Prof. Siegal Sadetzki as Chief Epidemiology Officer. With over three decades of experience in public health and epidemiology, Prof. Sadetzki brings a wealth of expertise to Briya's mission of making medical data accessible for research at scale and assisting hospitals in optimizing their data ...
mehrPress Release: Restless Legs Syndrome: Genetic Discoveries Advance Treatment and Risk Prediction
Researchers at Helmholtz Munich and the Technical University of Munich (TUM) together with international collaborators have conducted the largest genetic investigation of the restless legs syndrome to date. Their findings, ...
mehrKontrast Personalberatung GmbH
Postdocs for Core Informatics & PhD Students for Cyber-Physical Systems Wanted
Hamburg (ots) - Karlsruhe Institute of Technology launches two innovative research projects in cooperation with the Helmholtz Association The Karlsruhe Institute of Technology (KIT), one of Europe's leading technical universities, announces the launch of two groundbreaking research projects, which set new standards in basic research on cyber-physical systems and core ...
mehrResearchers: The future of democracy is on the ballot in Europe
mehrcanSERV invites applications for "Revolutionising Cancer Patient Care"
Ein DokumentmehrLAST CHANCE: canSERV Second Open Call for Cancer Research Service Provision
Ein DokumentmehrBosch Healthcare Solutions GmbH
Bosch and Randox: Strategic partnership brings highly multiplexing PCR to the point of care / BioMEMS technology enables fully automated, simultaneous testing for hundreds of genetic characteristics in just a few minutes
Waiblingen (ots) - - Bosch and Randox Laboratories Ltd. enter partnership for Vivalytic analysis platform to jointly invest around 150 million euros. - First test to feature novel BioMEMS technology will be a highly multiplexing sepsis IVD grade test. Bosch has agreed on a strategic partnership with Randox ...
mehrDr. Reddy's subsidiary betapharm, and Theranica launch Nerivio® in Germany to provide patients with drug-free migraine treatment
mehrARTCLINE successfully completes capital increases of EUR 4.4 million
Rostock, Germany (ots) - Today ARTCLINE GmbH announced the successful completion of two further capital increases. In addition to the founders, in particular family offices from Germany participated in the first capital increase of EUR 0.8 million. In addition, a convertible loan from investors was transferred to equity, so that a second capital increase of EUR 3.6 ...
mehr2022 Marked a Record for German R&D Investments
Berlin (ots) - EUR 121.4 billion was spent in Germany on reasearch and development - more than ever before in a single year. According to the Federal Statistical Office, the amount of money devoted to R&D rose by seven percent in 2022, reaching an all-time high. The figures include commercial, university and non-university research. R&D investments by businesses grew by eight percent, reaching EUR 81.8 billion. That's ...
mehr- 4
FDX Fluid Dynamix and Fraunhofer IPK to Collaborate with Lonza on Novel Nanoparticle Formulation Technology Platform FDmiX
mehr Research Success in Rare Disease / RHEACELL receives positive signal for accelerated stem cell development program in rare ‚Butterfly Disease‘
mehrLTS Lohmann Therapie-Systeme AG
First product based on LTS’ Sorrel(TM) wearable drug delivery platform launched in the US
mehrWhat Our Genetic Information Tells Us About Type 2 Diabetes Risk and Complications
mehrUniversità degli studi di Milano - Bicocca
Early Smartphone Use in Children? Two Studies Highlight Long-Term Consequences
Milan (ots) - A group of researchers from the University of Milano-Bicocca and SUPSI, by means of longitudinal data provided by INVALSI (Italian Institute for the Evaluation of the Education System), has confirmed that early smartphone usage before the age of 12 does not bring benefits. Instead, it is associated with lower digital skills, higher problematic smartphone ...
mehrThe ocean – a climate champion? How to boost marine carbon dioxide uptake
mehrLTS Lohmann Therapie-Systeme AG
LTS receives $4.3 Million grant for the development of contraceptive Microneedle Array Patches
mehrAntech launches first comprehensive veterinary diagnostics offering in the UK, including a new state-of-the-art reference laboratory
Warwick, England, 7 Nov. 2023 (ots/PRNewswire) - Antech to offer UK veterinary professionals a complete and flexible diagnostics portfolio spanning reference labs, in-house diagnostics, imaging and software Antech, the full-service veterinary diagnostics business that is part of the Science & Diagnostics division of ...
mehr- 2
PIONEER+ becomes Big Data Platform for Prostate Cancer of the EAU's UroEvidenceHub
mehr - 3
EU Provides 1 Mio. to Researchers to Advance Personalised Oncology
Ein Dokumentmehr canSERV Releases Open Call for Transnational Service Provision
Ein DokumentmehrHearing Loss Company Acousia Therapeutics Green Lighted for Game-Changing Phase 2 Trial
Tübingen, Germany (ots) - Acousia Therapeutics, a pioneer clinical-stage biotech company focused on the development of novel drug therapies for the prevention and treatment of acute and chronic forms of hearing loss, received approval from the German regulatory authorities (BfArM) for its groundbreaking Phase 2 clinical trial of the etiology-agnostic otoprotectant ...
mehrHearing loss company Acousia Therapeutics to present key learnings and data from lead development programs at US and European meetings in August and September
Tübingen, Germany (ots) - Acousia Therapeutics GmbH to share key learnings and data from its lead candidate development programs — clinical stage ACOU085 and late preclinical stage ACOU082 — during four presentations at industry and research meetings from August 29 to September 5. From August 29–31, Acousia ...
mehrLife Science Factory to Open a New Location in Munich in 2024
mehrGrünenthal and Kyowa Kirin International Announce Successful Completion of Deal to Enter Joint Venture Collaboration
Aachen, Germany and Tokyo, Japan (ots) - - The Joint Venture Collaboration includes a portfolio of 13 brands across six therapeutic areas, with the majority of revenue resulting from pain management medicines - The new enterprise will be branded as Grünenthal Meds. Grünenthal owns a 51 percent majority share and ...
mehrPatientGPT from Semalytix Will Replace Six Months of Evidence & Insight Generation in Life Science with Seconds
mehrRHEACELL announces “First Patient In”: EB-Haus in Salzburg, Austria starts pivotal study for stem cell therapy for severe forms of Epidermolysis bullosa that is longed for by those affected
mehr